NVDA
54
2
FCX
57
-2
AVY
54
-4
VRSK
82
2
SWK
67
-4
VTR
55
8
ETR
72
3
AVB
67
2
MMC
67
2
HPQ
66
6
GOOG
57
2
EMC
56
-3
MMM
42
5
COST
66
3
HUM
41
-2
VNO
68
3
DHI
52
-4
VFC
50
-2
TSCO
48
-3
INTC
40
-4
NVDA
54
2
FCX
57
-2
AVY
54
-4
VRSK
82
2
SWK
67
-4
VTR
55
8
ETR
72
3
AVB
67
2
MMC
67
2
HPQ
66
6
GOOG
57
2
EMC
56
-3
MMM
42
5
COST
66
3
HUM
41
-2
VNO
68
3
DHI
52
-4
VFC
50
-2
TSCO
48
-3
INTC
40
-4
Financhill
Back

Goldman Sachs Dynamic CA MuncplETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
19

GCAL
Goldman Sachs Dynamic CA MuncplETF

Last Price:
50.56
Seasonality Move:
--
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
19
Goldman Sachs Dynamic CA MuncplETF (GCAL) is a Sell

Is Goldman Sachs Dynamic CA MuncplETF a Buy, Sell or Hold?

  • The current Goldman Sachs Dynamic CA MuncplETF [GCAL] share price is $50.56. The Score for GCAL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • GCAL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GCAL Stock Price Chart

What is Goldman Sachs Dynamic CA MuncplETF's stock price today?

  • The Goldman Sachs Dynamic CA MuncplETF share price today is $50.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GCAL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GCAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 52.46 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.26 - 50.56) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

GCAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.57 Sell
20-day SMA: 50.43 Buy
50-day SMA: 50.65 Sell
200-day SMA: 0 Buy
8-day EMA: 50.54 Buy
20-day EMA: 50.5 Buy
50-day EMA: 50.55 Buy
200-day EMA: 1.49 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Goldman Sachs Dynamic CA MuncplETF Earnings Growth & GCAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Goldman Sachs Dynamic CA MuncplETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):